Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tri-Solfen for anesthesia before leg ulcer debridement
2018-000613-21Phase 2Unknown
- Sponsor
- Medical Ethics UK Ltd
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Tri-Solfen in leg ulcer (2 arms), sponsored by Medical Ethics UK Ltd. Primary endpoint: Safety and pharmacokinetics of Tri-Solfen. Status: unknown.
02
Drugs
Tri-Solfen
03
Conditions
leg ulcer
Beyond the preview
Go deeper on 2018-000613-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000613-21.